Skip to main content
Not yet activatedNot yet activated

Butyrate

Butyrate structure

Overview​

Butyrate is a short-chain fatty acid produced principally in the colon when microbes ferment suitable dietary substrates. It is an important colonocyte energy source and can influence epithelial barrier, immune and metabolic signalling. Within BRAIN, Butyrate is represented both as a biological input where direct evidence supports it and as a downstream target of fermentable-dietary-input relationships; those are not the same edge [1,2].

Evidence spans cell systems, animal models, human observational work and direct administration, with different doses and routes. Associations between altered SCFA profiles and neurological conditions do not establish deficiency, causality or a dietary treatment effect [3]. Claims about mitochondrial, inflammatory or brain outcomes therefore retain the exposure and model actually studied [3–5].

Dietary Context​

Most butyrate that reaches the colon is produced when gut microbes ferment suitable dietary substrates. Direct food content and that upstream route are different relationships [2].

Research Spotlights & Evidence Checks​

Foods​

Upstream substrate foods are displayed separately under Dietary pathways; they do not establish direct Butyrate content.

No verified direct food-content relationships are recorded. See upstream dietary pathways separately.

Recipes​

No recipes are linked through verified direct-content food relationships. Upstream dietary pathways are shown separately.

Biological Regulatory Systems​

Biological Regulatory SystemEvidence-qualified relationshipEvidence
Gut-Brain Axis & Enteric Nervous System (BRS5)PM1 retains the biological substrate and historical fibre records; its joined dietary resistant-starch–butyrate–tight-junction hypothesis remains unestablished[1,2]
Inflammation & Oxidative Stress (BRS3)Anti-inflammatory and redox findings are model- and route-dependent; altered SCFA profiles do not establish causality[3–5]
Mitochondrial Function & Bioenergetics (BRS4)Mitochondrial effects are supported principally by mechanistic and model evidence rather than ordinary food interventions[4,5]

References​

[1] Peng et al. (2009). Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase. Supports the direct epithelial-substrate relationship while remaining an experimental model rather than a dietary intake trial.

[2] Silva et al. (2020). The role of short-chain fatty acids from gut microbiota in gut-brain communication. Supports microbial formation from fermentable substrates and the distinction between upstream dietary provision and downstream Butyrate exposure.

[3] Fan et al. (2019). Short-chain fatty acids as potential regulators of brain and neurological diseases. Reviews neurological associations and mechanisms without establishing a universal Butyrate deficiency or food-treatment claim.

[4] Rose et al. (2018). Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism. Cell-model evidence relevant to mitochondrial mechanism, not a whole-food or clinical intervention.

[5] Cavaliere et al. (2022). Butyrate and its role in the gut-brain axis. Reviews route-dependent intestinal, immune and neurological mechanisms used to qualify BRS mappings.